Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury.

[1]  M. Gahr,et al.  Dynamic CpG-DNA Methylation of Il10 and Il19 in CD4+ T Lymphocytes and Macrophages: Effects on Tissue-Specific Gene Expression , 2011, Klinische Pädiatrie.

[2]  A. Rösen‐Wolff,et al.  Chronic non-bacterial osteomyelitis is associated with impaired Sp1 signaling, reduced IL10 promoter phosphorylation, and reduced myeloid IL-10 expression. , 2011, Clinical immunology.

[3]  Jhi-Joung Wang,et al.  Induced interleukin-19 contributes to cell-mediated immunosuppression in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. , 2011, The Annals of thoracic surgery.

[4]  K. Buzas,et al.  Myeloid cells migrate in response to IL-24. , 2011, Cytokine.

[5]  Gicheon Kim,et al.  Stat6 and c-Jun Mediate Th2 Cell-Specific IL-24 Gene Expression , 2011, The Journal of Immunology.

[6]  S. Rutz,et al.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.

[7]  J. Byun,et al.  The Expressions of TGF-β(1) and IL-10 in Cultured Fibroblasts after ALA-IPL Photodynamic Treatment. , 2011, Annals of dermatology.

[8]  K. O'Byrne,et al.  Epigenetics Underpinning the Regulation of the CXC (ELR+) Chemokines in Non-Small Cell Lung Cancer , 2011, PloS one.

[9]  J. Bream,et al.  Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4+ T cell activation; influence of IL-27. , 2010, Molecular immunology.

[10]  M. Gahr,et al.  IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA). , 2010, Clinical and experimental rheumatology.

[11]  G. Gallagher.  Interleukin-19: multiple roles in immune regulation and disease. , 2010, Cytokine & growth factor reviews.

[12]  Michael N. Alonso,et al.  Regulation of human Th9 differentiation by type I interferons and IL‐21 , 2010, Immunology and cell biology.

[13]  R. Misra,et al.  Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population , 2010, Rheumatology International.

[14]  F. Gao,et al.  Hypomethylation of IL10 and IL13 Promoters in CD4+ T Cells of Patients with Systemic Lupus Erythematosus , 2010, Journal of biomedicine & biotechnology.

[15]  A. Murphy,et al.  Interleukin‐19 protects mice from innate‐mediated colonic inflammation , 2010, Inflammatory bowel diseases.

[16]  J. Renauld,et al.  IL-22 defines a novel immune pathway of antifungal resistance , 2010, Mucosal Immunology.

[17]  G. Tiegs,et al.  Tolerance Induction in Response to Liver Inflammation , 2010, Digestive Diseases.

[18]  A. Paradowska-Gorycka,et al.  Interleukin‐10 gene promoter polymorphism in Polish rheumatoid arthritis patients , 2010, International journal of immunogenetics.

[19]  O. Silvennoinen,et al.  Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints , 2010, Scandinavian journal of rheumatology.

[20]  J. Bream,et al.  Cell type-specific regulation of IL-10 expression in inflammation and disease , 2010, Immunologic research.

[21]  P. Liang,et al.  IL-24 Transgenic Mice: In Vivo Evidence of Overlapping Functions for IL-20, IL-22, and IL-24 in the Epidermis , 2010, The Journal of Immunology.

[22]  K. Asadullah,et al.  The Th17 cytokine IL‐22 induces IL‐20 production in keratinocytes: A novel immunological cascade with potential relevance in psoriasis , 2009, European journal of immunology.

[23]  S. Winandy,et al.  Ikaros Is a Regulator of Il10 Expression in CD4+ T Cells1 , 2009, The Journal of Immunology.

[24]  K. Sayama,et al.  IL‐17 and IL‐22 mediate IL‐20 subfamily cytokine production in cultured keratinocytes via increased IL‐22 receptor expression , 2009, European journal of immunology.

[25]  Margarida Saraiva,et al.  Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.

[26]  A. Andoh,et al.  Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease , 2009, The Journal of Immunology.

[27]  M. Bijl,et al.  Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion? , 2009, Lupus.

[28]  Ming-Shi Chang,et al.  IL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke , 2009, The Journal of Immunology.

[29]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[30]  P. Fisher,et al.  Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24 , 2009, Cancer biology & therapy.

[31]  K. Asadullah,et al.  Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time‐dependent, and persisting immune effects of interleukin‐10 application in psoriasis , 2009, Journal of leukocyte biology.

[32]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[33]  Chien-Feng Li,et al.  Interleukin-20 targets renal mesangial cells and is associated with lupus nephritis. , 2008, Clinical immunology.

[34]  Yu-Hsiang Hsu,et al.  Interleukin-20 targets renal cells and is associated with chronic kidney disease. , 2008, Biochemical and biophysical research communications.

[35]  C.-C. Wei,et al.  A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis , 2008, Genes and Immunity.

[36]  P. Valdez,et al.  IL-22 in mucosal immunity , 2008, Mucosal Immunology.

[37]  R. Wu,et al.  Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. , 2008, The Journal of allergy and clinical immunology.

[38]  K. Hiromura,et al.  Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. , 2008, Rheumatology.

[39]  J. Bream,et al.  Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells , 2008, Genes and Immunity.

[40]  I. Behrmann,et al.  IL-24: a classic cytokine and/or a potential cure for cancer? , 2008, Journal of cellular and molecular medicine.

[41]  J. Steinke,et al.  The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. , 2008, The Journal of allergy and clinical immunology.

[42]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[43]  M. Blumenberg,et al.  Transcriptional responses of human epidermal keratinocytes to cytokine interleukin‐1 , 2008, Journal of cellular physiology.

[44]  Dinender K. Singla,et al.  p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. , 2007, American journal of physiology. Heart and circulatory physiology.

[45]  Christopher A Hunter,et al.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 , 2007, Nature Immunology.

[46]  S. Inoue,et al.  mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review). , 2007, International journal of oncology.

[47]  Chuan-Chih Hsu,et al.  IL-19 IS INVOLVED IN THE PATHOGENESIS OF ENDOTOXIC SHOCK , 2007, Shock.

[48]  J. Clausen,et al.  IL-20 gene expression is induced by IL-1β through mitogen-activated protein kinase and NF-κB-dependent mechanisms , 2007 .

[49]  Hyun-Dong Chang,et al.  Expression of IL‐10 in Th memory lymphocytes is conditional on IL‐12 or IL‐4, unless the IL‐10 gene is imprinted by GATA‐3 , 2007, European journal of immunology.

[50]  S. Sa,et al.  The Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in Psoriasis , 2007, The Journal of Immunology.

[51]  G. Adler,et al.  The murine liver is a potential target organ for IL-19, IL-20 and IL-24: Type I Interferons and LPS regulate the expression of IL-20R2. , 2007, Journal of hepatology.

[52]  K. Asadullah,et al.  Interleukin (IL)‐19, IL‐20 and IL‐24 are produced by and act on keratinocytes and are distinct from classical ILs , 2006, Experimental dermatology.

[53]  Anita K. Sharma,et al.  Interplay of TNF-α and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes , 2006 .

[54]  Werner Müller,et al.  Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA , 2006, European journal of immunology.

[55]  Kathleen M. Smith,et al.  IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesis , 2006, The Journal of experimental medicine.

[56]  C. Lewis,et al.  Novel IL10 gene family associations with systemic juvenile idiopathic arthritis , 2006, Arthritis research & therapy.

[57]  Ming-Fei Liu,et al.  Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. , 2006, Arthritis and rheumatism.

[58]  Miroslav M. Jovanović,et al.  Ultraviolet B Light Stimulates Interleukin-20 Expression by Human Epithelial Keratinocytes , 2006, Photochemistry and photobiology.

[59]  J. Krueger,et al.  Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. , 2006, The Journal of investigative dermatology.

[60]  Yu-Hsiang Hsu,et al.  Promoter analysis of interleukin 19. , 2006, Biochemical and biophysical research communications.

[61]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[62]  M.-S. Chang,et al.  Interleukin-20 promotes angiogenesis in a direct and indirect manner , 2006, Genes and Immunity.

[63]  Richard A. Flavell,et al.  Distal Enhancer Elements Transcribe Intergenic RNA in the IL-10 Family Gene Cluster1 , 2005, The Journal of Immunology.

[64]  L. Moldawer,et al.  Biology of interleukin-10 and its regulatory roles in sepsis syndromes. , 2005, Critical care medicine.

[65]  Margarida Saraiva,et al.  Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus1 , 2005, The Journal of Immunology.

[66]  T. Denning,et al.  Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis12 , 2005, The Journal of Immunology.

[67]  G. Radford-Smith,et al.  TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s disease , 2005, Journal of Medical Genetics.

[68]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[69]  Lihua Song,et al.  The Protooncogene c-Maf Is an Essential Transcription Factor for IL-10 Gene Expression in Macrophages1 , 2005, Journal of Immunology.

[70]  Lisa M. Toney,et al.  Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins1 , 2005, The Journal of Immunology.

[71]  K. Rajewsky,et al.  T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.

[72]  A. Rao,et al.  Chromatin-level Regulation of the IL10 Gene in T Cells* , 2004, Journal of Biological Chemistry.

[73]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[74]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[75]  S. Kõks,et al.  Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis , 2004, Genes and Immunity.

[76]  K. Kragballe,et al.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. , 2003, The Journal of investigative dermatology.

[77]  D. Hommes,et al.  Interleukin-10-based therapy for inflammatory bowel disease , 2003, Expert opinion on biological therapy.

[78]  K. Schenke-Layland,et al.  cAMP-induced Interleukin-10 Promoter Activation Depends on CCAAT/Enhancer-binding Protein Expression and Monocytic Differentiation* , 2003, The Journal of Biological Chemistry.

[79]  K. Madden,et al.  Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes , 2002, The Journal of Biological Chemistry.

[80]  J. Kjekshus,et al.  Inflammatory imbalance between IL‐10 and TNFα in unstable angina potential plaque stabilizing effects of IL‐10 , 2002, European journal of clinical investigation.

[81]  M. Boniotto,et al.  Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. , 2002, International immunopharmacology.

[82]  M. Retter,et al.  The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-241 , 2002, The Journal of Immunology.

[83]  K. Asadullah,et al.  Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members? , 2002, The Journal of Immunology.

[84]  S. Kotenko,et al.  Interleukin 24 (MDA-7/MOB-5) Signals through Two Heterodimeric Receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2* , 2002, The Journal of Biological Chemistry.

[85]  D. Lejeune,et al.  Cutting Edge: STAT Activation By IL-19, IL-20 and mda-7 Through IL-20 Receptor Complexes of Two Types1 , 2001, The Journal of Immunology.

[86]  U. Schindler,et al.  Cutting Edge: FISP (IL-4-Induced Secreted Protein), a Novel Cytokine-Like Molecule Secreted by Th2 Cells1 , 2001, The Journal of Immunology.

[87]  Francisco Diaz-Mitoma,et al.  The p38 Mitogen-activated Kinase Pathway Regulates the Human Interleukin-10 Promoter via the Activation of Sp1 Transcription Factor in Lipopolysaccharide-stimulated Human Macrophages* , 2001, The Journal of Biological Chemistry.

[88]  D. Conklin,et al.  Interleukin 20 Discovery, Receptor Identification, and Role in Epidermal Function , 2001, Cell.

[89]  S. Pestka,et al.  Cloning, expression and initial characterisation of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10) , 2000, Genes and Immunity.

[90]  S. Smale,et al.  A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages1 , 2000, The Journal of Immunology.

[91]  F. Nicoletti,et al.  Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency. , 1999, Autoimmunity.

[92]  H. Volk,et al.  Cyclic adenosine monophosphate‐responsive elements are involved in the transcriptional activation of the human IL‐10 gene in monocytic cells , 1999, European journal of immunology.

[93]  M. Leach,et al.  The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men" , 1999, Toxicologic pathology.

[94]  C. Copie-Bergman,et al.  Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. , 1998, The American journal of pathology.

[95]  O. Moine,et al.  Production and role of interleukin‐10 in concanavalin A–induced hepatitis in mice , 1997, Hepatology.

[96]  Z. Su,et al.  The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[97]  G. Trinchieri,et al.  Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10 , 1996, The Journal of experimental medicine.

[98]  Z. Su,et al.  Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. , 1995, Oncogene.

[99]  K. Rajewsky,et al.  Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. , 1995, The Journal of clinical investigation.

[100]  T. Standiford,et al.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. , 1995, Journal of immunology.

[101]  P. Vandenabeele,et al.  Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemia , 1994, European journal of immunology.

[102]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[103]  G. Trinchieri,et al.  Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.

[104]  M. Howard,et al.  Modified immunological status of anti-IL-10 treated mice. , 1993, Cellular immunology.

[105]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[106]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[107]  B. Cai,et al.  Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis , 2010, Molecular Biology Reports.

[108]  E Glowacka,et al.  IL-8, IL-12 and IL-10 cytokines generation by neutrophils, fibroblasts and neutrophils- fibroblasts interaction in psoriasis. , 2010, Advances in medical sciences.

[109]  Anita K. Sharma,et al.  Biology of TNFα and IL-10, and their imbalance in heart failure , 2008, Heart Failure Reviews.

[110]  L. Iversen,et al.  The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. , 2008, Cytokine.

[111]  H. Young,et al.  BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. , 2004, The Journal of biological chemistry.

[112]  F. Marincola,et al.  The dual role of IL-10. , 2003, Trends in immunology.

[113]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[114]  Jay K Kolls,et al.  The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .

[115]  B. Gao,et al.  Hydrodynamic Gene Delivery of Interleukin-22 Protects the Mouse Liver from Concanavalin A-, Carbon Tetrachloride-, and Fas Ligand-induced Injury via Activation of Stat3 Interleukin-22 (il-22) Is a Recently Identified T Cell-derived Cytokine Whose Biological Significance Remains Obscure. Previously, , 2022 .